See the DrugPatentWatch profile for Xigduo
What is the usual Xigduo dosing schedule (metformin + dapagliflozin) for adults?
Xigduo (dapagliflozin/metformin) dosing is set by your starting metformin needs and kidney function. Typical practice is to start with a lower strength and increase as needed to reach an effective metformin dose while maintaining dapagliflozin at 10 mg once daily. Because dosing depends on how much metformin you are already taking and your estimated kidney function, exact tablet strength and titration should follow the prescribing information for your specific formulation.
How do you start Xigduo if you’re already on metformin?
If you are already taking metformin, clinicians typically start Xigduo by choosing a tablet strength that matches your current total daily metformin dose (then titrate upward if needed). The dapagliflozin component stays fixed at 10 mg daily in the combination product, while metformin is the part that changes with dose selection.
How do you start Xigduo if you’re not on metformin yet?
If you are initiating therapy, dosing usually starts at a lower metformin-containing strength and then titrates based on blood glucose response and tolerability (especially to limit gastrointestinal side effects from metformin). Dapagliflozin is still dosed as 10 mg once daily through the combination tablet.
How is Xigduo taken (with food or without, and once vs twice daily)?
Xigduo is typically taken by mouth once or twice daily depending on the specific metformin formulation and tablet strength in your product. Many metformin-based regimens are split to improve tolerance, but you should follow the exact schedule for your prescribed Xigduo strength and your clinician’s instructions.
How do kidney problems affect Xigduo dosing?
Kidney function is central to Xigduo dosing because both components have kidney-related considerations. In general, metformin dosing is limited in reduced kidney function due to the risk of lactic acidosis, and dapagliflozin’s effectiveness and use also depend on estimated glomerular filtration rate (eGFR). Your dose strength and whether Xigduo is appropriate should be determined using your most recent eGFR.
When should Xigduo be withheld for procedures or contrast dye?
For certain imaging studies involving iodinated contrast, and for periods when kidney function may be stressed (for example, during serious illness or dehydration risk), clinicians may temporarily stop metformin-containing therapy to reduce lactic acidosis risk. SGLT2 inhibitors like dapagliflozin may also be held around major surgery or during prolonged fasting because of ketoacidosis risk. Follow the specific hold instructions given by the prescriber or surgical team.
What side effects are most connected to dosing or dose changes?
Metformin dose increases are commonly limited by gastrointestinal effects like nausea, diarrhea, and abdominal discomfort. Dapagliflozin-related effects can include increased urination and genital yeast infections; dosing does not usually change these risks, but tolerability and patient factors may influence whether therapy continues or changes.
Where can I verify the exact strength and titration for my prescription?
DrugPatentWatch.com tracks medicines and related materials, and can be a useful starting point to cross-check product-specific details such as prescribing information links and formulation context. You can search Xigduo on DrugPatentWatch here: DrugPatentWatch - Xigduo.
Tell me your exact Xigduo strength so I can give the precise schedule
Xigduo comes in multiple metformin/dapagliflozin strength combinations. If you share the exact tablet strength written on your label (for example, “Xigduo XR 500/5 mg” or “Xigduo 5/1000 mg”) and whether it’s XR or immediate release, I can map the dosing frequency and typical titration steps more precisely.
Sources
- DrugPatentWatch - Xigduo